FR2236504B1 - - Google Patents

Info

Publication number
FR2236504B1
FR2236504B1 FR7424501A FR7424501A FR2236504B1 FR 2236504 B1 FR2236504 B1 FR 2236504B1 FR 7424501 A FR7424501 A FR 7424501A FR 7424501 A FR7424501 A FR 7424501A FR 2236504 B1 FR2236504 B1 FR 2236504B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7424501A
Other versions
FR2236504A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19732336433 external-priority patent/DE2336433A1/de
Priority claimed from DE19732336434 external-priority patent/DE2336434A1/de
Priority claimed from DE19742426779 external-priority patent/DE2426779A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of FR2236504A1 publication Critical patent/FR2236504A1/fr
Application granted granted Critical
Publication of FR2236504B1 publication Critical patent/FR2236504B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
FR7424501A 1973-07-13 1974-07-15 Expired FR2236504B1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19732336433 DE2336433A1 (de) 1973-07-13 1973-07-13 1.3-oxygenierte 8 alpha-oestratriene
DE19732336434 DE2336434A1 (de) 1973-07-13 1973-07-13 1.3-oxygenierte 8 alpha-oestratriene
DE19742426778 DE2426778A1 (de) 1973-07-13 1974-05-31 1.3-oxygenierte 8alpha-oestratriene
DE19742426779 DE2426779A1 (de) 1974-05-31 1974-05-31 1.3-oxygenierte 8 alpha-oestratriene

Publications (2)

Publication Number Publication Date
FR2236504A1 FR2236504A1 (fr) 1975-02-07
FR2236504B1 true FR2236504B1 (fr) 1977-07-08

Family

ID=27431717

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7424501A Expired FR2236504B1 (fr) 1973-07-13 1974-07-15

Country Status (13)

Country Link
US (1) US3951958A (fr)
JP (1) JPS5032161A (fr)
BE (1) BE817599A (fr)
CA (1) CA1030950A (fr)
DK (1) DK132707C (fr)
FI (1) FI53577C (fr)
FR (1) FR2236504B1 (fr)
GB (1) GB1482285A (fr)
IE (1) IE39873B1 (fr)
IL (1) IL45260A (fr)
NL (1) NL7409489A (fr)
NO (1) NO742547L (fr)
SE (1) SE7409152L (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996359A (en) * 1972-05-19 1976-12-07 Ab Bofors Novel stereoisomeric component A of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steroid 21-acylates, compositions thereof, and method of treating therewith
IT1037092B (it) * 1974-12-13 1979-11-10 Farmila Farma Milano Tetraidopiranil eteri di estrugeni
US4096253A (en) * 1976-07-06 1978-06-20 Ortho Pharmaceutical Corporation 1-Oxygenated steroids
JP2552203Y2 (ja) * 1991-08-02 1997-10-29 株式会社フジクラ 電力ケーブルの接続部
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6903084B2 (en) * 1991-08-29 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3024256A (en) * 1961-02-20 1962-03-06 Searle & Co 16-substituted 1, 3-diacyloxyestra-1, 3, 5(10)-trien-17-ones
US3686238A (en) * 1970-01-19 1972-08-22 Syntex Corp Glycerol esterified with 2-naphthyl-acetic acids and fatty acids

Also Published As

Publication number Publication date
FI214074A (fr) 1975-01-14
DK132707C (da) 1976-07-12
GB1482285A (en) 1977-08-10
FI53577C (fi) 1978-06-12
NL7409489A (nl) 1975-01-15
SE7409152L (sv) 1975-01-14
US3951958A (en) 1976-04-20
NO742547L (fr) 1975-02-10
AU7112474A (en) 1976-01-15
FI53577B (fr) 1978-02-28
FR2236504A1 (fr) 1975-02-07
CA1030950A (fr) 1978-05-09
JPS5032161A (fr) 1975-03-28
IL45260A (en) 1978-03-10
IE39873L (en) 1975-01-13
IE39873B1 (en) 1979-01-17
DK368174A (fr) 1975-03-17
DK132707B (da) 1976-01-26
BE817599A (fr) 1975-01-13

Similar Documents

Publication Publication Date Title
AU476761B2 (fr)
AR201231Q (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU471343B2 (fr)
AU476714B2 (fr)
AU482620B2 (fr)
AR201229Q (fr)
AU472848B2 (fr)
AU476696B2 (fr)
AR199451A1 (fr)
AU477823B2 (fr)
AU471461B2 (fr)
AR196382A1 (fr)
AU476873B1 (fr)
AU477824B2 (fr)
AR193950A1 (fr)
AR195948A1 (fr)
AR197627A1 (fr)
AR195311A1 (fr)
AR200256A1 (fr)
AR200885A1 (fr)
AU461342B2 (fr)
AR196212Q (fr)

Legal Events

Date Code Title Description
ST Notification of lapse